- Home
- Life Sciences
- Pharmaceutical
- Drug and Medication
- Drug and Medication Analysis & Statistics, March 2013 (p3)
Talk to Alison
00 1 718 618 48 97
Search inside this page
Top countries
Publication dates
Publishers
- Global Data (482)
- Bioseeker (183)
- Global Research & Data Services (382)
- Global Markets Direct (753)
- Euromonitor International (422)
-
- Business Monitor International (3 620)
- Asia Market Information & Development Company (93)
- Infiniti Research Limited (47)
- GBI Research (37)
- Barnes Reports (8)
- Visiongain (59)
- MarketLine (47)
- Canadean Ltd (16)
- Currentpartnering (9)
- Espicom Business Intelligence (94)
- Greystone Research Associates (10)
- ICD Research (53)
- Ibisworld (11)
- La Merie Publishing (34)
- PMR Ltd. (6)
- Pacific Bridge Medical (3)
- RNCOS (10)
- Research In China (16)
- Transparency Market Research (9)
- TriMark Publications (4)
- World Market Intelligence Ltd (15)
- Chinascope Financial (25)
- Datamonitor (222)
- Life Science Analytics (LSA) (80)
- Frost & Sullivan (64)
- Global Industry Analyst (40)
- BCC Research (35)
- DrugPatentWatch - ThinkBiotech LLC (27)
- VacZine Analytics Group Of Assay Advantage Ltd (26)
- Kalorama Information (25)
- SCRIP Insights (24)
- Business Review (13)
- Aruvian's R'search (12)
- Koncept Analytics (12)
- BioPharm Reports (10)
- Daedal Research (10)
- Beijing Zeefer Consulting Ltd (9)
- Databank - Cerved Group (9)
- Venture Planning Group (9)
- CHI Insight Pharma Reports (8)
- Renub Research (8)
- CCM International Limited (6)
- Cygnus Business Consulting and Research (5)
- Firstword Pharma (5)
- Freedonia (5)
- Huidian Research (5)
- Ken Research Private (5)
- MarketsandMarkets (5)
- Lucintel (4)
- SeeNews - Research & Profiles (4)
- Urch Publishing (4)
- IData Research, Inc. (4)
- Emerging Markets Direct Media Holdings (3)
- Mintel (3)
- Netscribes (India) Pvt. Ltd. (3)
- Plimsoll Publishing Ltd UK (3)
- Access China Management Consulting Ltd. (2)
- Beremans Ltd (2)
- IPEXL (2)
- International Market Analysis Research and Consult (2)
- Arrowhead (1)
- Beijing HuaJing Ltd (1)
- Beijing Shennong Kexin Agribusiness Consulting Co. (1)
- Berlingske Research (1)
- BusinesStat (1)
- Dolcera Corporation (1)
- IndexBox Marketing (1)
- Key Note Publications Ltd (1)
- Leatherhead Food Research (1)
- Marketest (1)
- Reports from China (1)
- Smithers Rapra Technology Ltd (1)
- Strategic Defence Intelligence (SDI) (1)
- Xerfi (1)
- Zzz- Tiarta L.L.C (1)
All regions
-
- Algeria (23)
- Botswana (1)
- Burkina Faso (6)
- Cameroon (9)
- Central African Republic (6)
- Congo, Democratic Republic Of (1)
- Egypt (73)
- Eritrea (3)
- Ethiopia (10)
- Gabon (6)
- Gambia (1)
- Ghana (17)
- Guinea (6)
- Kenya (25)
- Libyan Arab Jamahiriya (1)
- Madagascar (10)
- Malawi (10)
- Mali (6)
- Mauritius (10)
- Morocco (29)
- Mozambique (8)
- Namibia (10)
- Niger (10)
- Nigeria (30)
- Senegal (14)
- South Africa (79)
- Sudan (5)
- Tanzania (4)
- Tunisia (10)
- Uganda (12)
- Zambia (9)
- Zimbabwe (19)
-
- Afghanistan (4)
- Armenia (15)
- Azerbaijan (17)
- Bahrain (17)
- Bangladesh (27)
- Bhutan (2)
- Cambodia (5)
- China (311)
- Georgia (18)
- India (209)
- Indonesia (43)
- Iran (36)
- Israel (134)
- Japan (288)
- Jordan (23)
- Kazakhstan (63)
- Kuwait (21)
- Kyrgyz Republic (kyrgyzstan) (4)
- Lebanon (49)
- Malaysia (44)
- Maldives (2)
- Mongolia (13)
- Nepal (10)
- Oman (59)
- Pakistan (31)
- Philippines (51)
- Qatar (18)
- Saudi Arabia (27)
- Singapore (47)
- South Korea (77)
- Sri Lanka (15)
- Syrian Arab Republic (10)
- Taiwan (38)
- Thailand (51)
- Turkey (20)
- United Arab Emirates (31)
- Uzbekistan (11)
- Vietnam (33)
- Yemen (11)
-
- Albania (5)
- Austria (21)
- Belarus (24)
- Belgium (45)
- Bosnia and Herzegovina (14)
- Bulgaria (69)
- Croatia (61)
- Cyprus (12)
- Czech Republic (110)
- Denmark (36)
- Estonia (55)
- Finland (36)
- France (130)
- Germany (136)
- Greece (122)
- Hungary (104)
- Iceland (11)
- Ireland (45)
- Italy (121)
- Latvia (66)
- Liechtenstein (1)
- Lithuania (26)
- Luxembourg (10)
- Macedonia (17)
- Malta (11)
- Moldova, Republic Of (55)
- Netherlands (53)
- Norway (24)
- Poland (139)
- Portugal (44)
- Romania (71)
- Russian Federation (172)
- Serbia and Montenegro (64)
- Slovakia (slovak Republic) (111)
- Slovenia (64)
- Spain (117)
- Sweden (53)
- Switzerland (51)
- Ukraine (70)
- United Kingdom (137)
-
- Australia (93)
- Austria (21)
- Belgium (45)
- Canada (157)
- Chile (71)
- Czech Republic (110)
- Denmark (36)
- Estonia (55)
- Finland (36)
- France (130)
- Germany (136)
- Greece (122)
- Hungary (104)
- Iceland (11)
- Ireland (45)
- Israel (134)
- Italy (121)
- Japan (288)
- Luxembourg (10)
- Mexico (105)
- Netherlands (53)
- New Zealand (33)
- Norway (24)
- Poland (139)
- Portugal (44)
- Slovenia (64)
- South Korea (77)
- Spain (117)
- Sweden (53)
- Switzerland (51)
- Turkey (20)
- United Kingdom (137)
- United States (671)
data types
Free Market Research Guides to Download
Drug and Medication Analysis & Statistics, March 2013 (p3)
You might be interested in: drug, vaccine, insulin, more »
» Purchase Premium Reports
61-100 of about 3 800 reports
Triple Analysis: Pancreatic Cancer, Apoptosis and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Each of these three individual parts ...
- Industries : Drug and Medication
Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Antibodies
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area ...
- Industries : Drug and Medication
Triple Analysis: Lung Cancer, Cancer Vaccines and Peptides
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides). ...
- Industries : Drug and Medication
Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...
- Industries : Drug and Medication
Triple Analysis: Melanoma, Cancer Vaccines and Protein Kinase Inhibitors
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual ...
- Industries : Drug and Medication
Triple Analysis: Melanoma, Pancreatic Cancer and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is ...
- Industries : Drug and Medication
Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Peptides
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area ...
- Industries : Drug and Medication
Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Protein Kinase Inhibitors
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three ...
- Industries : Drug and Medication
Triple Analysis: Prostate Cancer, Cancer Vaccines and Peptides
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area ...
- Industries : Drug and Medication
Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three ...
- Industries : Drug and Medication
Triple Analysis: Prostate Cancer, Cancer Vaccines and Antibodies
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area ...
- Industries : Drug and Medication
Triple Analysis: Prostate Cancer, Apoptosis and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Each of these three individual parts ...
- Industries : Drug and Medication
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts ...
- Industries : Drug and Medication
Triple Analysis: Prostate Cancer, Angiogenesis and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Each of these three individual parts ...
- Industries : Drug and Medication
Triple Analysis: Melanoma, Cancer Vaccines and Peptides
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides). ...
- Industries : Drug and Medication
Triple Analysis: Pancreatic Cancer, Angiogenesis and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Each of these three individual ...
- Industries : Drug and Medication
Triple Analysis: Lung Cancer, Prostate Cancer and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is ...
- Industries : Drug and Medication
Triple Analysis: Lymphoma, Angiogenesis and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Each of these three individual parts is ...
- Industries : Drug and Medication
Triple Analysis: Lung Cancer, Pancreatic Cancer and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts ...
- Industries : Drug and Medication
Triple Analysis: Melanoma, Apoptosis and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Each of these three individual parts is evaluated ...
- Industries : Drug and Medication
Triple Analysis: Lung Cancer, Cancer Vaccines and Protein Kinase Inhibitors
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual ...
- Industries : Drug and Medication
Triple Analysis: Lung Cancer, Lymphoma and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...
- Industries : Drug and Medication
Triple Analysis: Lymphoma, Apoptosis and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Each of these three individual parts is evaluated ...
- Industries : Drug and Medication
Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...
- Industries : Drug and Medication
Triple Analysis: Lymphoma, Prostate Cancer and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...
- Industries : Drug and Medication
Triple Analysis: Lymphoma, Cancer Vaccines and Peptides
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides). ...
- Industries : Drug and Medication
Triple Analysis: Lymphoma, Pancreatic Cancer and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is ...
- Industries : Drug and Medication
Triple Analysis: Melanoma, Angiogenesis and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Each of these three individual parts is ...
- Industries : Drug and Medication
Triple Analysis: Lymphoma, Melanoma and Cancer Vaccines
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...
- Industries : Drug and Medication
Triple Analysis: Lymphoma, Cancer Vaccines and Protein Kinase Inhibitors
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual ...
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_new Drug Certificate-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_production Of New Drugs That Go Through Relevant Reporting Procedures-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Export Amount-pharmaceuticals_chinese Patent Medicine-china-annual, In Usd (ten Thousands)
- $ 250
- Industry data
- May 2013
Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_new Drug Certificate And Production-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_imported Drug Re-registration-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_drug Filing-china-state Bureau-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Export Volume-pharmaceuticals_chinese Patent Medicine-china-annual, In Tonne (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_certificates And Production Of New Drugs That Go Through Relevant Reporting Procedures-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_drug Supplementary-china-provincial Bureau-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Ex-factory Price Indices Of Industrial Products-manufacture Of Medicines-china-yoy Growth-annual, In Preceding Year = 100
- $ 250
- Industry data
- May 2013
Yearly, From 1986 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
» Download Public Reports
About 11 000 reports
Value Of Manufacturers' Total Inventories For Nondurable Goods Industries: Chemical Products: Pharmaceuticals And Medicines
- Industry data
- February 2013
Monthly, From 1992 To 2012
Source: U.S. Department of Commerce: Census Bureau
Company Report: Drug For Year 2013
April 2013Drug Sector In Africa
April 2013Drug And Medication Industry Analysis
April 2013Medicine Sector In Malaysia
May 2013Vaccine Market In Tanzania
May 2013Drug Sector In Nigeria
May 2013» Read our Company Profiles
70 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandJohnson and Johnson
United StatesHealthcare Insurance
CanadaPfizer Inc.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
